On March 24, 2020, the company announced that it has entered into a long-term supply chain robustness agreement that will enable it to continue to provide high-quality, high-quality, and low-cost plasma.  The agreement is subject to approval by the U.S. Food and Drug Administration (FDA).  According to the company's press release, filed in federal court in Orlando, Florida on March 24, 2020, ADMA Biologics, Inc. ("ADMA"), a biopharmaceutical company based in Boca Raton, Florida, announced that it had entered into a long-term agreement with a U.S.-based company to provide high-quality, low-cost, and high-demand plasma.  The agreement provides for ADMA to provide high-quality, high-demand, high-quality, and low-cost, high-risk, high-risk, high-demand, high-risk, and low-cost, high-demand, high-demand, high-quality, high-quality, high-quality, low-risk, high-demand, high-quality, low-cost, high-demand, high quality, high-quality, high-quality, and high-quality, high-quality, high quality, high-quality, high quality, high quality, high-quality, and low-risk, high-risk, high-risk, low-risk, high-demand, low-cost, high-risk, low-cost, high-quality, high-risk, high-quality, high-demand, low-risk, low-risk, high-risk, low-cost, low-risk, high-risk, and low-risk, high-demand, high quality, high quality, high-risk, high-quality, low-risk, low-risk, low-cost, high-demand, low-risk, high-quality, high-risk, low-risk, low-risk, and high-quality, high-quality products.  ADMA Biologics also announced a $175 million debt refinancing with Morgan Stanley, which is subject to approval by the SEC.  ADMA Biologics has agreed to the terms of the settlement, which is subject to court approval.  The settlement is subject to approval by the SEC.  The company also agreed to pay a $25 million civil penalty.  The settlement is subject to court approval by the SEC.  The SEC's continuing investigation is being conducted by Heather Grossman, Kristen Kluska, and Barbara Lenz.  The SEC appreciates the assistance of the U.S. Food and Drug Administration, the U.S. Attorney's Office for the District of Florida, and the Federal Bureau of Investigation.